Hillsdale Investment Management’s BlueLinx BXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-29,900
Closed -$2.78M 606
2024
Q2
$2.78M Sell
29,900
-1,000
-3% -$106K 0.22% 166
2024
Q1
$4.02M Buy
30,900
+2,400
+8% +$282K 0.32% 123
2023
Q4
$3.23M Hold
28,500
0.26% 147
2023
Q3
$2.34M Sell
28,500
-100
-0.3% -$8.78K 0.21% 164
2023
Q2
$2.68M Sell
28,600
-2,600
-8% -$208K 0.25% 149
2023
Q1
$2.12M Sell
31,200
-40,300
-56% -$3.26M 0.18% 157
2022
Q4
$5.08M Buy
71,500
+200
+0.3% +$13.6K 0.43% 65
2022
Q3
$4.43M Sell
71,300
-1,400
-2% -$101K 0.4% 86
2022
Q2
$4.86M Sell
72,700
-11,450
-14% -$860K 0.39% 86
2022
Q1
$6.05M Sell
84,150
-200
-0.2% -$16.4K 0.39% 68
2021
Q4
$8.08M Sell
84,350
-12,950
-13% -$877K 0.54% 36
2021
Q3
$4.76M Sell
97,300
-200
-0.2% -$10.1K 0.37% 82
2021
Q2
$4.9M Sell
97,500
-12,200
-11% -$600K 0.39% 79
2021
Q1
$4.3M Buy
109,700
+108,400
+8,338% +$4.21M 0.36% 91
2020
Q4
$38K Buy
+1,300
New +$33.2K ﹤0.01% 449

Other funds holding BXC

Hillsdale Investment Management's BXC Position: Q3 2024 in Review

Hillsdale Investment Management sold out of BlueLinx (BXC) in Q3 2024, closing a stake of 29,900 shares — an estimated $2.78M sold.

Hillsdale Investment Management first reported a position in BXC in Q4 2020 and held it in 15 quarters. The position peaked at $8.08M in Q4 2021. 167 funds tracked by Wall St. Rank hold BXC as of Q3 2024.

  • Hillsdale Investment Management reported no remaining BlueLinx position as of Q3 2024 after selling out during the quarter.
  • Hillsdale Investment Management sold 29,900 BlueLinx shares in Q3 2024, an estimated $2.78M.
  • Hillsdale Investment Management first reported a position in BlueLinx in Q4 2020 and held it in 15 quarters.
  • Hillsdale Investment Management's BlueLinx position peaked at $8.08M in Q4 2021.
  • 167 funds tracked by Wall St. Rank held BlueLinx as of Q3 2024.

Based on Hillsdale Investment Management's 13F filing for Q3 2024, filed 12 Nov 2024.